A clinical case of refractory ventricular tachycardia treatment: from simple to complex and back again
https://doi.org/10.35336/VA-1522
Abstract
The article presents a clinical case of a patient with recurrent refractory ventricular tachycardia (VT) on the background of postinfarction cardiosclerosis. Despite optimal drug therapy and several catheter ablation procedures using modern navigation technologies, episodes of VT persisted. The key factor of ineffectiveness of the endocardial approach turned out to be the intramural location of arrhythmogenic zones. Therefore, a decision was made to perform surgical intervention with cryoablation of scar tissues. After the surgery, a stable remission was achieved, which was confirmed by the data of regular checks of the implantable cardioverter-defibrillator. The presented case emphasizes the importance of individualized and multidisciplinary approach in the choice of treatment tactics for patients with refractory VT.
Keywords
ventricular tachycardia,
catheter ablation,
cryoablation,
implantable cardioverter-defibrillator,
ischemic heart disease
Supporting agencies: none
About the Authors
A. G. Saribekian
FSBI «NMRC for Therapy and Preventive Medicine» of the MH RF
Russian Federation
Russian Federation
Anna Saribekian
Moscow, 10 Petroverigsky Lane
A. M. Abdullaev
FSBI «NMRC for Therapy and Preventive Medicine» of the MH RF
Russian Federation
Russian Federation
Moscow, 10 Petroverigsky Lane
K. V. Davtyan
FSBI «NMRC for Therapy and Preventive Medicine» of the MH RF
Russian Federation
Russian Federation
Moscow, 10 Petroverigsky Lane
E. R. Charchyan
FSBSI «RSC of Surgery named after Academician B.V. Petrovsky»
Russian Federation
Russian Federation
Moscow, 2 Abrikosovsky Lane
References
1. Mehra R. Global public health problem of sudden cardiac death. Journal of Electrocardiology. 2007 Nov;40(6): S118-22. http://doi.org/10.1016/j.jelectrocard.2007.06.023.
2. Roth GA, Abate D, Abate KH, et al. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 2018 Nov;392(10159): 1736-88. http://doi.org/10.1016/s0140-6736(18)32203-7.
3. Sapp JL, Wells GA, Parkash R, et al. Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs. New England Journal of Medicine. 2016 Jul 14;375(2): 111-21. http://doi.org/10.1056/nejmoa1513614.
4. Sapp JL, Tang ASL, Parkash R, et al. Catheter Ablation or Antiarrhythmic Drugs for Ventricular Tachycardia. New England Journal of Medicine. 2025 Feb 20;392(8): 737- 47. http://doi.org/10.1056/nejmoa2409501
5. Vissing CR, Axelsson Raja A, Day SM, et al. Cardiac Remodeling in Subclinical Hypertrophic Cardiomyopathy. JAMA Cardiology. 2023 Nov 1;8(11): 1083. http://doi.org/10.1001/jamacardio.2023.2808.
6. Hindricks G, Lenarczyk R, Kalarus Z, et al. Prevention of sudden cardiac death by the implantable cardioverter-defibrillator. Polish Archives of Internal Medicine. 2018 Dec 5; http://doi.org/10.20452/pamw.4386.
7. Zeppenfeld K, Tfelt-Hansen J, de Riva M, et al. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. European Heart Journal. 2022 Aug 26;43(40): 3997-4126. http://doi.org/10.1093/eurheartj/ehac262.
8. Josephson ME, Horowitz LN, Farshidi A, et al. Recurrent sustained ventricular tachycardia. 2. Endocardial mapping. Circulation. 1978 Mar;57(3): 440-7. http://doi.org/10.1161/01.cir.57.3.440.
9. Josephson ME, Horowitz LN, Farshidi A. Continuous local electrical activity. A mechanism of recurrent ventricular tachycardia. Circulation. 1978 Apr;57(4): 659-65. http://doi.org/10.1161/01.cir.57.4.659.
10. Della Bella P, Baratto F, Vergara P, et al. Does Timing of Ventricular Tachycardia Ablation Affect Prognosis in Patients With an Implantable Cardioverter Defibrillator? Results From the Multicenter Randomized PARTITA Trial. Circulation. 2022 Jun 21;145(25): 1829-38. http://doi.org/10.1161/circulationaha.122.059598.
11. Martinez BK, Baker WL, Konopka A, et al. Systematic review and meta-analysis of catheter ablation of ventricular tachycardia in ischemic heart disease. Heart Rhythm. 2020 Jan;17(1): e206-19. http://doi.org/10.1016/j.hrthm.2019.04.024.
12. Likoff W. Ventriculoplasty: excision of myocardial aneurysm. Journal of the American Medical Association. 1955 Jul 16;158(11): 915. http://doi.org/10.1001/jama.1955.02960110021006.
13. Mayer J, Al-Sheikhli J, Niespialowska-Steuden M, et al. Detailed analysis of electrogram peak frequency to guide ventricular tachycardia substrate mapping. Europace. 2024 Sep 29;26(10). http://doi.org/10.1093/europace/euae253.
14. Tonko JB, Lozano C, Moreno J, et al. Near-field detection and peak frequency metric for substrate and activation mapping of ventricular tachycardias in two- and three-dimensional circuits. Europace. 2024 Jun 4;26(7). http://doi.org/10.1093/europace/euae154.
Review
For citations:
Saribekian A.G., Abdullaev A.M., Davtyan K.V., Charchyan E.R. A clinical case of refractory ventricular tachycardia treatment: from simple to complex and back again. Journal of Arrhythmology. 2025;32(4):65-70. https://doi.org/10.35336/VA-1522
Views:
92
JATS XML
Email this article 